Emerging data suggest this peptide, a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to offer a promising step forward for body loss . Early clinical tests have demonstrated substantial losses in abdominal tissue, conceivably surpassing other body composition therapies . Despite this, fu